<DOC>
	<DOCNO>NCT01361802</DOCNO>
	<brief_summary>The development new Ambroxol spray formulation treatment sore throat pain associate acute pharyngitis require initial phase II study conduct order select appropriate dose pain relief .</brief_summary>
	<brief_title>Ambroxol Spray Sore Throat Study</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Ambroxol</mesh_term>
	<criteria>Inclusion criterion : 1 . Sore throat due acute pharyngitis ( 72 hour ) ; 2 . Score 6 great 11point pain intensity numerical rating scale ; 3 . Willingness remain study centre one hour follow first dose study medication return one three day later . 4 . Willing take nothing mouth except study medication three hour follow first intake study medication . Patients must also smoke time period . Exclusion criterion : 1 . Known allergy and/or hypersensitivity ambroxol , sorbitol , Acetaminophen ; 2 . Patients drug dependence and/or alcohol abuse ; 3 . Use throat lozenge , throat spray , cough drop , mentholcontaining product , product demulcent property within last 2 hour ; 4 . Use analgesic/antipyretic within last 4 hour ; 5 . Use `` cold medication '' ( e.g . decongestant , antihistamine , expectorant , antitussive ) within last eight hour ; 6 . Use antibiotic acute illness within last 24 hour ; 7 . Use inhaled steroid betaagonists continuous basis last week ; 8 . Use investigational therapy ( include market drug take investigational indication ) within last 30 day 9 . Any sign mouthbreathing due nasal congestion ; 10 . Cough cause throat discomfort ; 11 . Active pulmonary disease bronchopneumonia ; 12 . Pregnant , lactate breastfeed woman , 13 . Any medical psychiatric condition , opinion investigator , could increase risk associated participation investigational study affect compliance protocol . 14 . Patients previously enrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>